Regenerative Medicine Market, By Therapy (Stem Cell Therapy (Autologous, Allogeneic), Tissue Engineering, Immunotherapy, Gene Therapy and Others), By Application (Dermatology, Orthopedic & Musculoskeletal Disorders, Cardiology, Diabetes, Oncology, Central Nervous System and Others) – Global Industry Insights, Trends and Forecast, 2017-2025

Created On: Jun-2018
Report ID: IR58
Format: PDF

Regenerative Medicine Market: Introduction

Regenerative medicine refers to such medicines that are used to replace, repair and regenerate the organs and tissues that are affected by disease, injury or natural aging process. Such medicines restore the tissue and cell functionality and several degenerative disorders such as cardiovascular problems, neurodegenerative diseases, dermatology and orthopedic problems.

Market Dynamics

Emergence of stem cell technology in the application on medicines and prevent chronic diseases such as heart, Parkinson’s among others is resulting to the growth of the regenerative medicines market. For instance, induced pluripotent stem cells (iPSCs) grab more attention because of their advantages related to therapeutic that enables to generate high-quality disease models. Untapped potential of nanotechnology are also generating opportunity to the global regenerative medicine market size in recent years. Nontechnology plays an important role in the cancer diagnostics as it helps to detect cancer at advanced stages and thus helps to provide proper treatment for the patients.

 In addition to this advancement of the surgical technologies and monitoring devices has also resulted to the rise in the growth of the for regenerative medicine market share across the globe. For instance, preference toward regenerative medicines during facial reconstructive surgery has been widely adopted by the patients in recent years. According to CDC (Centers for Disease Control and Prevention) in 2012 approximately 117 million individuals in the U.S. had one or more health conditions that are chronic. In addition to this there is also rise in the prevalence of acute wounds such as traumatic and surgical wounds across the globe. Increase in the prevalence of bone injuries including osteoporosis and arthritis are is further anticipated to fuel the growth of global regenerative medicine market size. However, high cost of regenerative medicines and stem cell therapy treatment can restrict the growth of this market. The average costing of stem cell therapy across the globe starts at around US$ 7,000 – US$ 8,000.

By Therapy

Stem cell therapy segment is expected to grow constantly over the forecast period, due to its potential in restoring the function of affected tissues and organs. Furthermore, gene therapy segment is also expected to rise over the forecast period, owing to increased research and development activities in technologies such as gene editing and gene sequencing. Advancements in technology and launch of new technologies, such as Cas9, a gene editing platform, by companies like CRISPR Therapeutics is indicating towards the bright future of gene therapy segment in the global regenerative medicine market size over the projected period.

By Application

In the application segment, regenerative medicine market size for dermatology is expected to dominate the market in terms of revenue, due to availability of simple grafting techniques for skin-related diseases. Presence of a wide product folio of regenerative medicines, patches, and grafts for rectifying skin burn and other skin issues is anticipated to drive the growth of this segment.

Regional Insights

In terms of region wise study, the global regenerative medicine market size has been segmented into North America, Europe, Asia Pacific, Middle East, Africa and Latin America. North America dominated the market owing to the rising adoption of regenerative medicines among the patients. Strong research and development has resulted to the growth of the regenerative medicine market in recent years. For instance, Ontario competes for research strength in regenerative medicine with the major academic clusters in United States. Regulations in U.S. are hampering the market however; Canada is witnessed to generate opportunity to further develop the research strength on regenerative medicines in the coming years.

Competitive Landscape

Some of the major players operating in the global regenerative medicine market are Athersys, Inc., Integra Lifesciences Corporation, Isto Biologics (Isto Biologics Medical Systems, Inc.), Acelity Holdings, Inc. (Lifecell Corporation), Medtronic Plc, Organogenesis Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Cryolife, Inc., among others. Key market players are focusing on merger and acquisition activities to enhance their product portfolio and global reach. For instance, in August 2017, Tissue Regenix, a UK-based company, announced the acquisition of US-based CellRight Technologies with the aim to expand their research & development pipelines and to extend their global presence.

Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Reach Out to us